Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0820
-0.0030 (-3.53%)
Jun 26, 2026, 2:28 PM AEST
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 33.78 million as of June 26, 2026. Its market cap has increased by 186.66% in one year.
Market Cap
33.78M
Enterprise Value
30.96M
Revenue
6.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 33.78M, a decrease of -65.65%. That is a compound annual growth rate of -17.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 33.78M | 37.24% |
| Dec 31, 2025 | 24.61M | 62.80% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Epiminder | 69.23M |
| Cleo Diagnostics | 65.01M |
| Compumedics | 47.94M |
| HeraMED | 43.98M |
| CleanSpace Holdings | 31.56M |
| Nova Eye Medical | 29.91M |
| Micro-X | 23.94M |
| Memphasys | 21.61M |